CIBC Asset Management Inc Has $2.70 Million Holdings in The Clorox Company (NYSE:CLX)

CIBC Asset Management Inc cut its position in The Clorox Company (NYSE:CLX) by 5.8% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 19,812 shares of the company’s stock after selling 1,215 shares during the quarter. CIBC Asset Management Inc’s holdings in Clorox were worth $2,704,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of the company. SG Americas Securities LLC grew its position in Clorox by 1,525.7% in the 1st quarter. SG Americas Securities LLC now owns 65,612 shares of the company’s stock worth $10,046,000 after purchasing an additional 61,576 shares during the last quarter. Mizuho Markets Americas LLC grew its position in Clorox by 93.7% in the 1st quarter. Mizuho Markets Americas LLC now owns 72,053 shares of the company’s stock worth $11,032,000 after purchasing an additional 34,864 shares during the last quarter. CANADA LIFE ASSURANCE Co grew its position in Clorox by 15.2% in the 1st quarter. CANADA LIFE ASSURANCE Co now owns 141,622 shares of the company’s stock worth $21,705,000 after purchasing an additional 18,687 shares during the last quarter. Advisors Asset Management Inc. grew its position in Clorox by 257.5% in the 1st quarter. Advisors Asset Management Inc. now owns 11,228 shares of the company’s stock worth $1,719,000 after purchasing an additional 8,087 shares during the last quarter. Finally, Game Plan Financial Advisors LLC acquired a new stake in Clorox in the 1st quarter worth $1,025,000. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Clorox Trading Up 0.4 %

Shares of NYSE CLX opened at $164.77 on Friday. The Clorox Company has a 1-year low of $114.68 and a 1-year high of $165.71. The company has a market cap of $20.46 billion, a PE ratio of 85.37, a P/E/G ratio of 3.21 and a beta of 0.39. The company has a current ratio of 1.03, a quick ratio of 0.63 and a debt-to-equity ratio of 5.04. The company has a 50-day moving average of $142.37 and a two-hundred day moving average of $142.82.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Thursday, August 1st. The company reported $1.82 EPS for the quarter, topping the consensus estimate of $1.54 by $0.28. Clorox had a net margin of 3.95% and a return on equity of 281.12%. The company had revenue of $1.90 billion during the quarter, compared to analysts’ expectations of $1.97 billion. As a group, equities analysts expect that The Clorox Company will post 6.56 earnings per share for the current fiscal year.

Clorox Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, August 30th. Stockholders of record on Wednesday, August 14th were given a dividend of $1.22 per share. This is a boost from Clorox’s previous quarterly dividend of $1.20. The ex-dividend date was Tuesday, August 13th. This represents a $4.88 annualized dividend and a dividend yield of 2.96%. Clorox’s payout ratio is currently 252.85%.

Analyst Upgrades and Downgrades

Several research firms have issued reports on CLX. JPMorgan Chase & Co. decreased their price target on shares of Clorox from $150.00 to $148.00 and set a “neutral” rating on the stock in a research report on Friday, August 2nd. Argus raised shares of Clorox to a “hold” rating in a report on Tuesday, June 4th. TD Cowen began coverage on shares of Clorox in a report on Tuesday, July 23rd. They set a “sell” rating and a $122.00 price objective for the company. Wells Fargo & Company reduced their price objective on shares of Clorox from $135.00 to $130.00 and set an “underweight” rating for the company in a report on Wednesday, July 10th. Finally, Deutsche Bank Aktiengesellschaft raised their price objective on shares of Clorox from $144.00 to $151.00 and gave the stock a “hold” rating in a report on Friday, August 2nd. Six research analysts have rated the stock with a sell rating and thirteen have assigned a hold rating to the company. According to MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $143.19.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.